SCHEMBL427259

SCHEMBL427259

CN(C(=O)n1cnc(-c2ccc(S(=O)(=O)N3CCC(OCc4ccccc4)CC3)cc2)c1)C1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.53
CES2 O00748 1/20 0.53
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
GFER P55789 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KAT8 Q9H7Z6 2/20 0.39
KAT6A Q92794 1/20 0.39
CHRM5 P08912 2/20 0.39
F13A1 P00488 1/20 0.39
TGM2 P21980 1/20 0.39
TGM1 P22735 1/20 0.39
TRPV1 Q8NER1 2/20 0.39
TRPA1 O75762 1/20 0.39
MGLL Q99685 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
USP2 O75604 2/20 0.38
GAA P10253 3/20 0.38
USP19 O94966 1/20 0.38
MMP2 P08253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL426108 0.84 FAAH (0.60) FAAHCES2MEN1KMT2AGFER
SCHEMBL427990 0.82 FAAH (0.52) FAAHCES2KAT8KAT6ATRPV1
SCHEMBL428087 0.81 FAAH (0.59) FAAHCES2MEN1KMT2AGFER
SCHEMBL525315 0.81 FAAH (0.58) FAAHCES2TRPV1TRPA1MGLL
SCHEMBL424383 0.77 FAAH (0.74) FAAHCES2MEN1KMT2AALDH1A1
SCHEMBL14937796 0.77 FAAH (0.47) FAAHCES2USP19
SCHEMBL14937794 0.77 FAAH (0.47) FAAHCES2USP19
SCHEMBL526198 0.77 FAAH (0.58) FAAHCES2MEN1KMT2ATRPV1
SCHEMBL426096 0.77 FAAH (0.67) FAAHCES2KMT2AALDH1A1SMN1; SMN2
SCHEMBL426004 0.76 FAAH (0.66) FAAHCES2KMT2AALDH1A1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9353082-B2 Pharmaceutical compounds BIAL—PORTELA & CA, S.A. (PT) 2016-05-31 US disclosed
US-9353082-B2 Pharmaceutical compounds BIAL—PORTELA & CA, S.A. (PT) 2016-05-31 US disclosed
US-20120065191-A1 PHARMACEUTICAL COMPOUNDS BIAL - PORTELA & Cª, S.A. (PT) 2012-03-15 US disclosed
US-20120065191-A1 PHARMACEUTICAL COMPOUNDS BIAL - PORTELA & Cª, S.A. (PT) 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065191-A1 PHARMACEUTICAL COMPOUNDS FAAH, FAAH2, ASAH1 FAAH 1/4885CES2 62/4885MEN1 2893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.